Of course, some couples may be open to that delay if they are actively pursuing metabolic health support for the woman
Our firm has a long history of holding powerful corporations accountable when unsafe products cause real harm, and we are bringing that same approach to emerging pharmaceutical litigation
GLP-1-directed delivery of the NMDA receptor antagonist MK-801 affects neuroplasticity in the hypothalamus and brainstem
The FDA has studied cyanocobalamin for subcutaneous administration, giving it a more established safety profile via injection
One is Virta Health, which advertises its nutrition-focused weight management program as "a proven approach for deprescribing GLP-1s when clinically appropriate." A Virta-funded study assessed 154 people with Type 2 diabetes who stopped using GLP-1 medications but continued following Virta's program, concluding that their weight did not significantly increase after a year
Sex differences in the cardiovascular consequences of diabetes mellitus: a Scientific Statement From the American Heart Association
